[1]
de la Torre C, Villamor P. Chemically Assisted Dissection With Sodium 2-Mercaptoethanesulfonate (MESNA) in the Surgical Management of Pediatric Cholesteatoma. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2019 Jun:40(5):645-650. doi: 10.1097/MAO.0000000000002174. Epub
[PubMed PMID: 31083092]
[2]
Jaiswal SR, Singhal P, Thatai A, Bhagwati G, Aiyer HM, Chakrabarti A, Chakrabarti S. Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation. Annals of hematology. 2020 Apr:99(4):839-845. doi: 10.1007/s00277-020-03930-w. Epub 2020 Feb 5
[PubMed PMID: 32025839]
[3]
Ismi O, Karabulut YY, Bal KK, Vayisoglu Y, Unal M. Single dose intratympanic mesna application inhibits propylene glycol induced cholesteatoma formation. The Journal of laryngology and otology. 2017 Mar:131(3):215-220. doi: 10.1017/S002221511600983X. Epub 2016 Dec 20
[PubMed PMID: 27995828]
[4]
Carassiti M, Di Martino A, Centonze A, Quattrocchi CC, Caldaria A, Agrò F, Denaro V. Failed back surgery syndrome: a new strategy by the epidural injection of MESNA. Musculoskeletal surgery. 2018 Aug:102(2):179-184. doi: 10.1007/s12306-017-0520-x. Epub 2017 Nov 2
[PubMed PMID: 29098646]
[5]
de la Torre González C, Huante-Guido M, Velázquez Guadarrama N, Preciado D, Patiño López G. Changes in biofilm in chronic cholesteatomatous otitis media in children following the application of sodium 2-mercaptoethanesulfonate (MESNA). International journal of pediatric otorhinolaryngology. 2018 Jul:110():48-52. doi: 10.1016/j.ijporl.2018.04.020. Epub 2018 Apr 23
[PubMed PMID: 29859586]
[6]
Manikandan R, Kumar S, Dorairajan LN. Hemorrhagic cystitis: A challenge to the urologist. Indian journal of urology : IJU : journal of the Urological Society of India. 2010 Apr:26(2):159-66. doi: 10.4103/0970-1591.65380. Epub
[PubMed PMID: 20877590]
[8]
Jahanbakhsh S, Dekhne MS, Kohan-Ghadr HR, Bai D, Awonuga A, Morris RT, Yang Z, Abu-Soud HM. The inhibition of lactoperoxidase catalytic activity through mesna (2-mercaptoethane sodium sulfonate). Journal of inorganic biochemistry. 2020 Feb:203():110911. doi: 10.1016/j.jinorgbio.2019.110911. Epub 2019 Nov 12
[PubMed PMID: 31734539]
[9]
Cutler MJ, Velenosi TJ, Bodalia A, House AA, Urquhart BL, Freeman DJ. Enzymatic and non-enzymatic mechanisms of dimesna metabolism. Amino acids. 2015 Mar:47(3):511-23. doi: 10.1007/s00726-014-1882-0. Epub 2014 Dec 10
[PubMed PMID: 25488427]
[10]
Sannu A, Radha R, Mathews A, Padmakumari Mony R, Prahladan A, James FV. Ifosfamide-Induced Malignancy of Ureter and Bladder. Cureus. 2017 Aug 22:9(8):e1594. doi: 10.7759/cureus.1594. Epub 2017 Aug 22
[PubMed PMID: 29062626]
[11]
Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A 3rd, von Hoff D, Schuchter LM. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1:27(1):127-45. doi: 10.1200/JCO.2008.17.2627. Epub 2008 Nov 17
[PubMed PMID: 19018081]
Level 1 (high-level) evidence
[12]
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney international. 2021 Oct:100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021. Epub
[PubMed PMID: 34556256]
Level 1 (high-level) evidence
[13]
. ACOG Committee Opinion No. 747 Summary: Gynecologic Issues in Children and Adolescent Cancer Patients and Survivors. Obstetrics and gynecology. 2018 Aug:132(2):535-536. doi: 10.1097/AOG.0000000000002764. Epub
[PubMed PMID: 30045207]
Level 3 (low-level) evidence
[14]
Ninane J, Baurain R, de Kraker J, Ferster A, Trouet A, Cornu G. Alkylating activity in serum, urine, and CSF following high-dose ifosfamide in children. Cancer chemotherapy and pharmacology. 1989:24 Suppl 1():S2-6; discussion S7
[PubMed PMID: 2503256]
[15]
Sridharan K, Hasan HM, Al Jufairi M, Al Daylami A, Al Ansari E, Qader AM, Pasha SAA. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates. Expert opinion on drug safety. 2020 Dec:19(12):1625-1640. doi: 10.1080/14740338.2020.1805431. Epub 2020 Aug 21
[PubMed PMID: 32767900]
Level 3 (low-level) evidence
[16]
Sarfraz S, Saeed H. Feasibility and safety of outpatient administration of ifosfamide and etoposide for pediatric patients with Ewing sarcoma in a resource-limited setting amid the COVID-19 pandemic. Pediatric blood & cancer. 2022 May:69(5):e29595. doi: 10.1002/pbc.29595. Epub 2022 Mar 2
[PubMed PMID: 35234343]
Level 2 (mid-level) evidence
[17]
Orobello N, Harrington C, Reilly BK. Updates in paediatric cholesteatoma. Current opinion in otolaryngology & head and neck surgery. 2022 Dec 1:30(6):422-425. doi: 10.1097/MOO.0000000000000850. Epub 2022 Sep 21
[PubMed PMID: 36165030]
Level 3 (low-level) evidence
[18]
Eğilmez OK, Kökten N, Baran M, Kalcıoğlu MT, Doğan Ekici I, Tekin M. Electrophysiological and Histopathological Evaluation of Effects of Sodium-2 Mercaptoethanesulfonate Used for Middle Ear Surgery on Facial Nerve Functions. The journal of international advanced otology. 2018 Aug:14(2):239-244. doi: 10.5152/iao.2017.3888. Epub
[PubMed PMID: 29283098]
[19]
Matz EL, Hsieh MH. Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis. Urology. 2017 Feb:100():16-19. doi: 10.1016/j.urology.2016.07.030. Epub 2016 Aug 24
[PubMed PMID: 27566144]
Level 3 (low-level) evidence
[20]
Soria A, Lebrun-Vignes B, Le Forestier N, Francès C. Fixed Drug Eruption Due to Mesna. Journal of investigational allergology & clinical immunology. 2015:25(6):444-5
[PubMed PMID: 26817144]
[21]
Lin CY, Keefe M. Mesna-induced photodistributed dermatosis. Clinical and experimental dermatology. 2012 Jun:37(4):358-60. doi: 10.1111/j.1365-2230.2011.04233.x. Epub 2011 Nov 21
[PubMed PMID: 22103595]
[22]
Khaw SL, Downie PA, Waters KD, Ashley DM, Heath JA. Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide. Pediatric blood & cancer. 2007 Sep:49(3):341-3
[PubMed PMID: 16333822]
[23]
Ercan N, Aysegul E, Burcak B, Ilknur B. Sepsis like acute hypersensitivity syndrome related to mesna. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017 Sep:31(9):e393-e394. doi: 10.1111/jdv.14198. Epub 2017 Apr 19
[PubMed PMID: 28271573]
[24]
Robertson LM, Clark A. Looking beyond the angiotensin receptor blocker: A case of anaphylaxis to mesna. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2016 Sep:117(3):324-5. doi: 10.1016/j.anai.2016.06.023. Epub 2016 Jul 14
[PubMed PMID: 27424127]
Level 3 (low-level) evidence
[25]
Nikolac Gabaj N, Miler M, Unic A, Milevoj Kopcinovic L, Vrtaric A, Culej J. Ascorbic acid in urine still compromises urinalysis results. Annals of clinical biochemistry. 2020 Jan:57(1):64-68. doi: 10.1177/0004563219882051. Epub 2019 Oct 23
[PubMed PMID: 31569954]
[26]
Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. American family physician. 2005 Mar 15:71(6):1153-62
[PubMed PMID: 15791892]
[27]
Shimogori K, Araki M, Shibazaki S, Tuda K, Miura K. Nonimmediate allergic reactions induced by Mesna. Journal of general and family medicine. 2017 Oct:18(5):285-287. doi: 10.1002/jgf2.79. Epub 2017 Jun 22
[PubMed PMID: 29264044]
[28]
Fukuda H, Kamidani R, Okada H, Kitagawa Y, Yoshida T, Yoshida S, Ogura S. Complex poisoning mainly with benzyl alcohol complicated by paralytic ileus: a case report. International journal of emergency medicine. 2022 Jul 4:15(1):31. doi: 10.1186/s12245-022-00434-4. Epub 2022 Jul 4
[PubMed PMID: 35787785]
Level 3 (low-level) evidence
[29]
King AM, Danagoulian S, Lynch M, Menke N, Mu Y, Saul M, Abesamis M, Pizon AF. The Effect of a Medical Toxicology Inpatient Service in an Academic Tertiary Care Referral Center. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2019 Jan:15(1):12-21. doi: 10.1007/s13181-018-0684-2. Epub 2018 Oct 23
[PubMed PMID: 30353414]
[30]
O'Leary KJ, Johnson JK, Manojlovich M, Goldstein JD, Lee J, Williams MV. Redesigning systems to improve teamwork and quality for hospitalized patients (RESET): study protocol evaluating the effect of mentored implementation to redesign clinical microsystems. BMC health services research. 2019 May 8:19(1):293. doi: 10.1186/s12913-019-4116-z. Epub 2019 May 8
[PubMed PMID: 31068161]
Level 2 (mid-level) evidence
[31]
Golom FD, Schreck JS. The Journey to Interprofessional Collaborative Practice: Are We There Yet? Pediatric clinics of North America. 2018 Feb:65(1):1-12. doi: 10.1016/j.pcl.2017.08.017. Epub
[PubMed PMID: 29173710]
[32]
Bentley M, Freeman T, Baum F, Javanparast S. Interprofessional teamwork in comprehensive primary healthcare services: Findings from a mixed methods study. Journal of interprofessional care. 2018 May:32(3):274-283. doi: 10.1080/13561820.2017.1401986. Epub 2017 Nov 28
[PubMed PMID: 29182411]